1. Home
  2. RDY vs FHN Comparison

RDY vs FHN Comparison

Compare RDY & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • FHN
  • Stock Information
  • Founded
  • RDY 1984
  • FHN 1864
  • Country
  • RDY India
  • FHN United States
  • Employees
  • RDY N/A
  • FHN N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • FHN Major Banks
  • Sector
  • RDY Health Care
  • FHN Finance
  • Exchange
  • RDY Nasdaq
  • FHN Nasdaq
  • Market Cap
  • RDY 12.1B
  • FHN 11.0B
  • IPO Year
  • RDY N/A
  • FHN N/A
  • Fundamental
  • Price
  • RDY $13.79
  • FHN $21.36
  • Analyst Decision
  • RDY Strong Buy
  • FHN Buy
  • Analyst Count
  • RDY 2
  • FHN 17
  • Target Price
  • RDY $16.95
  • FHN $23.26
  • AVG Volume (30 Days)
  • RDY 1.5M
  • FHN 9.9M
  • Earning Date
  • RDY 07-23-2025
  • FHN 07-16-2025
  • Dividend Yield
  • RDY 0.52%
  • FHN 2.80%
  • EPS Growth
  • RDY 2.20
  • FHN 28.03
  • EPS
  • RDY 0.79
  • FHN 1.55
  • Revenue
  • RDY $3,897,394,052.00
  • FHN $3,083,000,000.00
  • Revenue This Year
  • RDY $7.61
  • FHN $11.02
  • Revenue Next Year
  • RDY $1.89
  • FHN $3.61
  • P/E Ratio
  • RDY $17.40
  • FHN $13.84
  • Revenue Growth
  • RDY 15.86
  • FHN 4.55
  • 52 Week Low
  • RDY $12.26
  • FHN $14.72
  • 52 Week High
  • RDY $16.89
  • FHN $23.00
  • Technical
  • Relative Strength Index (RSI)
  • RDY 40.12
  • FHN 47.79
  • Support Level
  • RDY $13.32
  • FHN $20.97
  • Resistance Level
  • RDY $14.86
  • FHN $21.77
  • Average True Range (ATR)
  • RDY 0.23
  • FHN 0.49
  • MACD
  • RDY -0.05
  • FHN -0.16
  • Stochastic Oscillator
  • RDY 31.29
  • FHN 26.90

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About FHN First Horizon Corporation

First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.

Share on Social Networks: